Description
A selective inhibitor of the HER2, inhibiting HER2 phosphorylation with an IC50 value of 6 nM; without effect on EGFR, FGFR, PDGFR, Jak1, Src, and Blk (IC50 > 25 μM); inhibits the proliferation of breast, bladder, kidney, and prostate cancer cells in vitro and in vivo
Formal name: 1-[4-[4-[[2-[(1E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
Synonyms: TAK-165
Molecular weight: 468.5
CAS: 366017-09-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|EGFR/ErbB/HER Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling